College of Art and Science, Northeast Agricultural University, Harbin, People's Republic of China.
Experimental Seafood Processing Laboratory, Coastal Research and Extension Center, Mississippi State University, Pascagoula, Mississippi, USA.
J Food Sci. 2022 Mar;87(3):1082-1095. doi: 10.1111/1750-3841.16054. Epub 2022 Feb 10.
In order to search for suitable soybean varieties for different applications, the protein contents of Kunitz trypsin inhibitor (KTI), Bowman-Birk trypsin inhibitor (BBI), glycinin (11S), and β-conglycinin (7S) of 93 soybean samples from different sources and harvest years were quantified by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Meanwhile, the protease inhibitory activities against trypsin and chymotrypsin were determined. Results showed that the individual protein contents and trypsin inhibitor activities differed significantly (p < 0.05) among soybean samples. KTI contents ranged from 5.25 to 14.60 mg·g ; BBI contents ranged from 1.81 to 5.74 mg·g ; 11S varied from 13.65% to 48.55% and 7S varied from 15.68% to 42.15% of total soluble protein; trypsin and chymotrypsin inhibitory activities were 8.93-20.95 mg TI·g and 4.18 -12.79 mg CI·g , respectively. Excellent linear relationships existed between trypsin inhibitor contents and their activities. The regression equations offer a rapid method for estimating the activity of KTI or BBI in raw soybeans. PRACTICAL APPLICATION: The regression equations established based on a large number of soybean varieties offered a rapid method to estimate the activity of trypsin inhibitors. The data presented here provided useful information for the food industry or breeders to select soybean varieties with different inhibitory activities or protein contents for different food processing applications.
为了寻找适用于不同应用的大豆品种,采用十二烷基硫酸钠聚丙烯酰胺凝胶电泳法对 93 个不同来源和收获年份的大豆样品中的 Kunitz 胰蛋白酶抑制剂(KTI)、Bowman-Birk 胰蛋白酶抑制剂(BBI)、球蛋白(11S)和β-伴大豆球蛋白(7S)的含量进行了定量分析,并同时测定了它们对胰蛋白酶和糜蛋白酶的抑制活性。结果表明,大豆样品之间的个体蛋白含量和胰蛋白酶抑制剂活性差异显著(p<0.05)。KTI 含量范围为 5.25-14.60mg·g;BBI 含量范围为 1.81-5.74mg·g;11S 占总可溶性蛋白的 13.65%-48.55%,7S 占 15.68%-42.15%;胰蛋白酶和糜蛋白酶抑制活性分别为 8.93-20.95mg TI·g 和 4.18-12.79mg CI·g。KTI 或 BBI 含量与其活性之间存在良好的线性关系。回归方程为快速估计生大豆中 KTI 或 BBI 活性提供了一种方法。该研究为食品工业或育种者提供了有用的信息,以便根据不同的食品加工应用选择具有不同抑制活性或蛋白含量的大豆品种。